Mirtazapine Tablet, Film Coated
Product Images NDC 87441-058

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mirtazapine (NDC 87441-058). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Unit Dose Solutions, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Mirtazapine 15 mg (8744105801 Mirtazapine 15 mg)

Mirtazapine 15 mg (8744105801 Mirtazapine 15 mg)
Label for Mirtazapine Tablets USP, 15 mg, Rx only, film-coated oral tablets. The label includes instructions for pharmacists to dispense the Medication Guide to each patient and storage conditions at 25°C with allowed excursions. It is repackaged by Unit Dose Solutions, Inc. and distributed by Tuckahoe Enterprises, LLC. The label also mentions keeping the medication out of reach of children.*
FDA Label Image

Mirtazpine Structure (Mirtazapine Str)

Mirtazpine Structure (Mirtazapine Str)
Chemical structure diagram of the active ingredient Mirtazapine, showing its molecular framework with multiple nitrogen-containing rings and a methyl group attached.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.